Resverlogix collaborates with Emerald Logic to identify factors driving drug response
Resverlogix announced it has completed a research program with Emerald Logic. Using Fast Collective Evolution Technology, Emerald Logic analyzed Resverlogix's complete clinical dataset including all measurements obtained from each of 798 patients who participated in the Phase 2 clinical trials. March 04, 2015